Fig. 3

Antithrombotic therapy status at bleeding. Among 21 patients who received heparin as a bridge to anticoagulant medication and experienced post-procedural bleeding, the timing of bleeding was analyzed with the timing classified into five categories from A to E according to the antithrombotic therapy status at bleeding. A, before post-procedural resumption of heparin; B, after resumption of heparin but before resumption of oral antithrombotic therapy; C, during concomitant use of heparin and an anticoagulant; D, during concomitant use of three drugs of heparin, an anticoagulant, and an antiplatelet drug; E, after the end of heparin bridging and during oral antithrombotic therapy. The percentages at the bottom indicate the proportions of patients who had bleeding during the time periods